AIM: To study the effect of MSCT vascular reconstruction and chemoembolization through portal vein and liver artery in patients with liver cancer metastases.
目的研究MSCT血管重建和双重化疗栓塞治疗转移性肝癌的效果。
CONCLUSION: Vascular restructure with MSCT and chemoembolization through portal vein and liver artery, with no obvious side-effects, are effective for patients with liver cancer metastases.
结论用MSCT血管重建和肝动脉、门静脉双重化疗栓塞治疗转移性肝癌有一定临床效果，且无明显毒副作用。
Transcatheter arterial chemoembolization therapy in the treatment of hepatocellular carcinoma with tumor thrombus of portal vein.
放射介入栓塞化疗对肝癌合并门静脉癌栓治疗的疗效观察。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective to study the clinical effectiveness of arterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis.
目的探讨原发肝癌合并门静脉瘤栓的化学栓塞治疗。
Objective to study the clinical effectiveness of arterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis.
目的探讨原发肝癌合并门静脉瘤栓的化学栓塞治疗。
应用推荐